Anti-EIF2AK1 monoclonal antibody

Pre-made anti-EIF2AK1 monoclonal antibody(mab)-benchmark antibody for ELISA, affinity binding assay, drug discovery and mechanism of action (MOA) research

Target products collectionGo to EIF2AK1/EIF2AK1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-T02439-Ab-1/ GM-Tg-hg-T02439-Ab-2Anti-Human EIF2AK1 monoclonal antibodyHuman
GM-Tg-rg-T02439-Ab-1/ GM-Tg-rg-T02439-Ab-2Anti-Rat EIF2AK1 monoclonal antibodyRat
GM-Tg-mg-T02439-Ab-1/ GM-Tg-mg-T02439-Ab-2Anti-Mouse EIF2AK1 monoclonal antibodyMouse
GM-Tg-cynog-T02439-Ab-1/ GM-Tg-cynog-T02439-Ab-2Anti-Cynomolgus/ Rhesus macaque EIF2AK1 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-T02439-Ab-1/ GM-Tg-felg-T02439-Ab-2Anti-Feline EIF2AK1 monoclonal antibodyFeline
GM-Tg-cang-T02439-Ab-1/ GM-Tg-cang-T02439-Ab-2Anti-Canine EIF2AK1 monoclonal antibodyCanine
GM-Tg-bovg-T02439-Ab-1/ GM-Tg-bovg-T02439-Ab-2Anti-Bovine EIF2AK1 monoclonal antibodyBovine
GM-Tg-equg-T02439-Ab-1/ GM-Tg-equg-T02439-Ab-2Anti-Equine EIF2AK1 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-T02439-Ab-1/ GM-Tg-hg-T02439-Ab-2; GM-Tg-rg-T02439-Ab-1/ GM-Tg-rg-T02439-Ab-2;
GM-Tg-mg-T02439-Ab-1/ GM-Tg-mg-T02439-Ab-2; GM-Tg-cynog-T02439-Ab-1/ GM-Tg-cynog-T02439-Ab-2;
GM-Tg-felg-T02439-Ab-1/ GM-Tg-felg-T02439-Ab-2; GM-Tg-cang-T02439-Ab-1/ GM-Tg-cang-T02439-Ab-2;
GM-Tg-bovg-T02439-Ab-1/ GM-Tg-bovg-T02439-Ab-2; GM-Tg-equg-T02439-Ab-1/ GM-Tg-equg-T02439-Ab-2
Products NameAnti-EIF2AK1 monoclonal antibody
Formatmab
Target NameEIF2AK1
Protein Sub-locationIntrocelluar Protein
Category of antibodyTherapeutics Target antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by ELISA with recombinant soluble protein antigen. The potency in neutralizing, inhibiting or blocking of the target protein is not detected.
TagFc
Products descriptionPre-made anti-EIF2AK1 monoclonal antibody(mab) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenGM-Tg-g-T02439-Ag-1Recombinant multi-species E2AK1/ EIF2AK1/ HCR protein
    ORF Viral VectorvGMLP0024730 EIF2AK1 Lentivirus particle
    ORF Viral VectorpGMLP002473human EIF2AK1 Lentivirus plasmid


    Target information

    Target IDGM-T02439
    Target NameEIF2AK1
    Gene ID27102,15467,27137,703325,100302056,101081103,507689,100062309
    Gene Symbol and SynonymsEIF2AK1,HCR,hHRI,HRI,LEMSPAD
    Uniprot AccessionQ9BQI3,Q63185
    Uniprot Entry NameE2AK1_HUMAN,E2AK1_RAT
    Protein Sub-locationIntrocelluar Protein
    CategoryTherapeutics Target
    DiseaseN/A
    Gene EnsemblENSG00000086232
    Target ClassificationKinase

    The target: EIF2AK1, gene name: EIF2AK1, also named as HCR, HRI. The protein encoded by this gene acts at the level of translation initiation to downregulate protein synthesis in response to stress. The encoded protein is a kinase that can be inactivated by hemin. Two transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2008].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.